about
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic AdenocarcinomaAdult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo.MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.CRISPR/Cas9: Transcending the Reality of Genome Editing.Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.Signal transduction of somatostatin receptors negatively controlling cell proliferation.MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancerThe rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic toolTargeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors.Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.Salivary MicroRNA in Pancreatic Cancer Patients.Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.Tie1 deficiency induces endothelial-mesenchymal transition.IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic CancerPancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.Long-term gene expression in dividing and nondividing cells using SV40-derived vectors.Potential of recombinant SV40-based vectors for gene therapy.Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas.miRNA in clinical practice: pancreatic cancer.DNA methylation and cancer diagnosis.Molecular endoscopic ultrasound for diagnosis of pancreatic cancer.The Promise of Gene Therapy for Pancreatic Cancer.The Role of the 3' Untranslated Region in the Post-Transcriptional Regulation of KLF6 Gene Expression in Hepatocellular CarcinomaTargeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.Hopes, Promises, and Future Directions of Gene and Cell Therapies in France.The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth.Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery diseaseRegulating the expression of therapeutic transgenes by controlled intake of dietary essential amino acids.Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
P50
Q27853365-CD181AE5-DDF7-41A5-9F5C-9F12B236397DQ33483354-52CE2AFF-286F-47F4-BB25-BEF1C637B048Q33525784-E873C1D8-02E7-4B07-A4AC-4FDD04D76CBCQ33632925-5E0CC4FD-85BE-4DAA-8224-EA86798A71E3Q33988953-FA2863CB-5CDF-4C64-9477-5CF365909A6FQ34067856-41A88D7D-04D2-43A1-B810-00295E4632A7Q34087753-A2D83BA5-DFE9-4081-9018-ED8FC0182DB7Q34093798-AFFA40AF-9E28-4898-A546-8B901456696FQ34576658-D684E753-DF59-4BDE-A8BF-FBDFCC378FCCQ35078434-302AA7AF-0AEB-4E03-B63E-0421A991B32EQ35199203-C8B26D14-0550-4210-9DE2-AE1AB10694B9Q35399221-8CF53E58-0338-4084-A34C-D02026A61456Q35677442-258B3F81-7191-4EB7-8D6A-E9B349EF70DCQ35695360-89B554F3-9CD9-4223-9296-743004255AA8Q35761199-9FCB33C8-E549-43FD-9B3C-4D4F7BAC5E0DQ35931790-62E93A3C-E10D-42D0-8119-F38DD6C756C2Q36296837-A04F15EE-2FC9-49C1-9683-1D24AE70292CQ36443870-71481EFE-7B18-4A7B-BFA7-241F50572D00Q36654542-885961A4-5985-44DD-992A-7F0917CCA2D3Q36685600-B5B35726-65DE-4E67-9F6C-B100907E5EEFQ37347918-85592942-6789-429E-B673-7F1A59B300F3Q37509767-1C2D38BC-577B-49A5-B31C-C64C8C002230Q38097575-F6CBEA70-3D4C-427F-B7D5-63BB051E336DQ38123094-51AAC418-5733-4844-9ABB-BCC6346F28C0Q38161338-0CD08DC4-49E8-4B61-9FF9-EBB26C81E263Q38646753-9A38F01F-6513-455B-9C2C-C1CFD2420C23Q38671852-B91B434E-53BA-454F-94C0-C2EA73948A9DQ38688079-F9876871-E6DD-460E-909E-40C874674E3CQ38737478-5F4C65CE-4F13-47E7-80D2-E466F4B93867Q38943997-59A230E9-E497-4A8B-A34C-220E99AFF5E9Q38953240-2E1ABDCE-4E5F-4578-A873-8DACC23F3D74Q39359422-05AFB42A-DE2E-40BA-A398-802B4C5553DBQ39402566-B46B574F-EC5E-403E-8E51-FB836759BEA5Q39709103-F1AC7184-2D98-4952-8B7A-330AD0B9595BQ40227847-89E50B8F-D082-40E9-99AA-D7470E1CA0CCQ40625143-61C6589F-FC00-4098-874B-2FF1CBCCABA3Q41905591-2C76EBCC-1ED7-4185-AE30-CC8378CF2A98Q42321217-AADE617C-9718-4E73-ABD1-10E4124896C4Q42494301-418CB74A-3EAF-42EA-92C1-3BBF785500C7Q42508870-72200A4B-3D98-4BD9-94CE-653D024C31CC
P50
description
researcher ORCID ID = 0000-0003-2096-7967
@en
wetenschapper
@nl
name
Pierre Cordelier
@ast
Pierre Cordelier
@en
Pierre Cordelier
@es
Pierre Cordelier
@nl
type
label
Pierre Cordelier
@ast
Pierre Cordelier
@en
Pierre Cordelier
@es
Pierre Cordelier
@nl
prefLabel
Pierre Cordelier
@ast
Pierre Cordelier
@en
Pierre Cordelier
@es
Pierre Cordelier
@nl
P106
P31
P496
0000-0003-2096-7967